FY2026 Earnings Forecast for ISRG Issued By Erste Group Bank

Intuitive Surgical, Inc. (NASDAQ:ISRG) – Investment analysts at Erste Group Bank cut their FY2026 EPS estimates for Intuitive Surgical in a research report issued on Thursday, April 2nd. Erste Group Bank analyst H. Engel now forecasts that the medical equipment provider will post earnings of $8.21 per share for the year, down from their prior estimate of $8.22. The consensus estimate for Intuitive Surgical’s current full-year earnings is $6.43 per share.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. The company had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. Intuitive Surgical’s quarterly revenue was up 18.8% on a year-over-year basis. During the same period in the previous year, the business posted $2.21 earnings per share.

A number of other research analysts have also commented on the stock. Sanford C. Bernstein lifted their price objective on shares of Intuitive Surgical from $740.00 to $750.00 and gave the company an “outperform” rating in a research note on Friday, January 23rd. TD Cowen upgraded shares of Intuitive Surgical to a “strong-buy” rating in a research note on Tuesday, January 27th. Zacks Research lowered shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 30th. Royal Bank Of Canada boosted their price target on shares of Intuitive Surgical from $625.00 to $650.00 and gave the stock an “outperform” rating in a research note on Wednesday, December 17th. Finally, Robert W. Baird dropped their price target on shares of Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating on the stock in a research note on Friday, January 23rd. One analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $607.00.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $454.94 on Thursday. The firm has a market cap of $161.56 billion, a PE ratio of 57.66, a P/E/G ratio of 3.61 and a beta of 1.68. Intuitive Surgical has a one year low of $427.84 and a one year high of $603.88. The firm’s fifty day moving average is $482.22 and its two-hundred day moving average is $513.65.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Riversedge Advisors LLC grew its position in Intuitive Surgical by 1.9% during the fourth quarter. Riversedge Advisors LLC now owns 901 shares of the medical equipment provider’s stock worth $510,000 after buying an additional 17 shares during the period. Fiduciary Financial Group LLC grew its position in Intuitive Surgical by 2.1% during the fourth quarter. Fiduciary Financial Group LLC now owns 920 shares of the medical equipment provider’s stock worth $521,000 after buying an additional 19 shares during the period. Prosperity Consulting Group LLC grew its position in Intuitive Surgical by 0.5% during the third quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider’s stock worth $1,804,000 after buying an additional 19 shares during the period. Rossmore Private Capital grew its position in Intuitive Surgical by 2.0% during the third quarter. Rossmore Private Capital now owns 998 shares of the medical equipment provider’s stock worth $446,000 after buying an additional 20 shares during the period. Finally, Activest Wealth Management grew its position in Intuitive Surgical by 21.7% during the third quarter. Activest Wealth Management now owns 112 shares of the medical equipment provider’s stock worth $50,000 after buying an additional 20 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, SVP Mark Brosius sold 2,362 shares of the company’s stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $498.68, for a total transaction of $1,177,882.16. Following the transaction, the senior vice president directly owned 3,554 shares in the company, valued at approximately $1,772,308.72. This represents a 39.93% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Gary S. Guthart sold 24,500 shares of the company’s stock in a transaction dated Tuesday, January 27th. The stock was sold at an average price of $530.10, for a total transaction of $12,987,450.00. Following the transaction, the director owned 3,694 shares in the company, valued at $1,958,189.40. The trade was a 86.90% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 32,943 shares of company stock valued at $17,279,568. Insiders own 0.60% of the company’s stock.

Key Headlines Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Company forecasts procedure growth of ~13–15% in 2026, signaling durable demand for da Vinci systems and continued international expansion — a core driver of recurring system, instrument and services revenue that supports a premium valuation. Can 13-15% Procedure Growth in 2026 Sustain ISRG’s Premium Valuation?
• Positive Sentiment: Management’s AI initiative for surgical decision support and precision enhancements reinforces the long‑term growth narrative and could expand service/software monetization beyond hardware. That roadmap supports multiple‑year upside if outcomes and adoption follow. Intuitive Surgical’s AI Push Tests Valuation And Da Vinci Growth Story
• Positive Sentiment: Analyst commentary highlights ISRG’s financial strength (no net debt) and dominant market position in robotic‑assisted surgery — factors that support defensive earnings visibility and higher multiples relative to peers. This Healthcare Stock Has No Debt and a Near-Monopoly in Its Market
• Neutral Sentiment: ISRG recently posted an intra‑session advance but still underperformed the broader market, indicating mixed investor appetite despite positive fundamentals. Short‑term volatility may persist around news flow and macro data. Intuitive Surgical, Inc. (ISRG) Advances But Underperforms Market: Key Facts
• Neutral Sentiment: Goldman Sachs lowered its price target from $714 to $609 but kept a Buy rating — a signal that confidence in the story remains but upside expectations were trimmed, which can cap near‑term momentum. Goldman Sachs Adjusts Price Target on Intuitive Surgical to $609
• Neutral Sentiment: Erste Group made very small trims to FY2026/FY2027 EPS estimates (rounding adjustments only), implying analysts are largely tracking management guidance but remain watchful for macro or reimbursement shifts. Erste Group Analyst Note / MarketBeat Summary
• Negative Sentiment: Evercore published a pessimistic forecast for ISRG’s stock price, adding downside narrative that can influence sentiment and increase selling pressure among more defensive investors. Evercore Issues Pessimistic Forecast for Intuitive Surgical

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.